PROJECT

Projects

Summary of Investment Information

Project Number

47125

Company Name

GRUPO FARMANOVA-INTERMED GFI S.A.

Date SPI Disclosed

Mar 8, 2024

Country

Costa Rica

Region

Latin America and the Caribbean

Projected Board Date

Apr 9, 2024

Environmental Category

B - Limited

Status

Active

Last Updated Date

Dec 20, 2024

Department

Regional Industry MAS LAC & EUR

Industry

other

Previous Events

Approved : Jun 12, 2024
Signed : Nov 18, 2024
Invested : Dec 18, 2024

Sector

other

Project Description

Grupo Farmanova Intermed (“GFI” or the “Group”) is a private, family-owned group engaged in pharmaceutical distribution, commercialization, and retail both for human and animal health. GFI is headquartered in Costa Rica with operations throughout Central America and the Caribbean. As part of its growth in the region, GFI is investing in capital expenditure to consolidate its distribution operations into a single facility, acquiring licenses for commercialization of medications in the region, and other general corporate proceeds including working capital and repayment of debt (“the Project”).

Associated Advisory Engagement

IFC’s upstream team is supporting GFI with its innovative DigiPharma Advisory tool, which is working with the Group to identify areas for digital improvements.  

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation